Kalweit Gabriel, Ullrich Evelyn, Boedecker Joschka, Mertelsmann Roland, Kalweit Maria
Collaborative Research Institute Intelligent Oncology (CRIION), Freiburg, Baden-Württemberg, 79110, Germany.
Department of Computer Science, University of Freiburg, Freiburg, Baden-Württemberg, 79110, Germany.
Oxf Open Immunol. 2025 May 12;6(1):iqaf004. doi: 10.1093/oxfimm/iqaf004. eCollection 2025.
The molecular complexity of cancer presents significant challenges to traditional therapeutic approaches, necessitating the development of innovative treatment strategies capable of addressing the disease's dynamic nature and resistance mechanisms. Data-driven methodologies, particularly those employing Artificial Intelligence (AI), hold substantial promise by advancing a comprehensive understanding of the intricate molecular and cellular mechanisms underlying cancer and supporting the development of adaptive, patient-specific therapeutic strategies. Initiated through the Mertelsmann Foundation, the Collaborative Research Institute Intelligent Oncology (CRIION) in Freiburg im Breisgau, Germany, aims to drive progress in AI-driven oncology. CRIION fosters global collaboration through initiatives like the Intelligent Oncology Symposium and supports multidisciplinary projects designed to integrate AI innovations into clinical workflows.
癌症的分子复杂性给传统治疗方法带来了重大挑战，因此需要开发能够应对该疾病动态特性和耐药机制的创新治疗策略。数据驱动的方法，特别是那些采用人工智能（AI）的方法，通过促进对癌症潜在的复杂分子和细胞机制的全面理解，并支持开发适应性强、针对患者的治疗策略，具有巨大的潜力。由默特尔斯曼基金会发起的德国弗赖堡市的智能肿瘤学合作研究所（CRIION）旨在推动人工智能驱动的肿瘤学发展。CRIION通过智能肿瘤学研讨会等倡议促进全球合作，并支持旨在将人工智能创新融入临床工作流程的多学科项目。
